Literature DB >> 2888024

Effects of dopamine receptor antagonists on gastrin and vomiting responses to apomorphine.

M Goiny, K Uvnäs-Moberg.   

Abstract

Apomorphine (0.05 mg/kg intravenously) was given to conscious dogs, and gastrin levels were measured in peripheral venous blood with a radioimmunoassay. Apomorphine induced an increase of gastrin levels which peaked at 5 min. The peripheral dopamine D-2/DA2 receptor antagonist domperidone (0.2 mg/kg), but not halopemide (0.1-1 mg/kg) nor the D-1/DA1 receptor antagonist SCH 23,390 (0.1 mg/kg), blocked the gastrin response to apomorphine. Both domperidone and halopemide, but not SCH 23,390, blocked the apomorphine-induced vomiting. These results suggest that apomorphine increases gastrin levels by an action at D-2/DA2 receptors, which are situated outside the blood brain barrier and differ from the receptor inducing the vomiting.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2888024     DOI: 10.1007/bf00177745

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  33 in total

1.  Physiology and pharmacology of vomiting.

Authors:  H L BORISON; S C WANG
Journal:  Pharmacol Rev       Date:  1953-06       Impact factor: 25.468

Review 2.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

3.  Increased plasma gastrin levels in connection with inhibition of gastric acid responses to sham feeding following bulbar perfusion with acid in dogs.

Authors:  G Nilsson
Journal:  Scand J Gastroenterol       Date:  1975       Impact factor: 2.423

4.  Dopamine in human gastric juice determined by a sensitive double-isotope-derivative technique.

Authors:  N J Christensen; O Brandsborg
Journal:  Scand J Clin Lab Invest       Date:  1974-12       Impact factor: 1.713

5.  SCH 23390 is a very potent and selective antagonist at vascular dopamine receptors.

Authors:  A Hilditch; G M Drew; R J Naylor
Journal:  Eur J Pharmacol       Date:  1984-01-27       Impact factor: 4.432

6.  Effect of cholinergic, adrenergic, and dopaminergic blockade on gastrin secretion in healthy subjects.

Authors:  E Schrumpf; P Linnestad
Journal:  Scand J Gastroenterol       Date:  1982-01       Impact factor: 2.423

7.  Peripheral pre- and post-synaptic dopamine receptors: are they different from dopamine receptors in the central nervous system?

Authors:  L I Goldberg; J D Kohli
Journal:  Commun Psychopharmacol       Date:  1979

8.  Disturbed islet-cell function related to endogenous gastrin release. Studies on insulin secretion and glucose tolerance in pernicious anemia.

Authors:  J F Rehfeld
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

9.  On the ability of domperidone to selectively inhibit catecholamine-induced relaxation of circular smooth muscle of guinea-pig stomach.

Authors:  H A Sahyoun; B Costall; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1982-01       Impact factor: 3.765

10.  A comparison of domperidone and haloperidol effects on different dopaminergic neurons in the rat brain.

Authors:  J M Farah; K T Demarest; K E Moore
Journal:  Life Sci       Date:  1983-10-17       Impact factor: 5.037

View more
  3 in total

Review 1.  Dopamine in gastrointestinal disease.

Authors:  G B Glavin; S Szabo
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

2.  A long lasting gastrin response to apomorphine revealed by inhibitors of gastric acid secretion.

Authors:  M Goiny; K Brodin; C E Elwin; K Uvnäs-Moberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

Review 3.  The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Authors:  Manon Auffret; Sophie Drapier; Marc Vérin
Journal:  Drugs R D       Date:  2018-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.